Shareholder Votes

SHOPIFY INC. shareholders approved Non-binding Advisory Vote on Executive Compensation at the 2026-06-16 meeting.

“Name of Nominee Votes For Votes Against Broker Non-Votes Number Percentage Number Percentage Number Tobias Lütke 1,657,446,737 97.72% 38,629,744 2.28% 76,273,736 Lulu Cheng Meservey 1,691,141,695 99.71% 4,934,787 0.29% 76,273,736 Jeanne DeWitt Grosser 1,684,061,536 99.29% 12,014,945 0.71% 76,273,736 David Heinemeier Hansson 1,691,045,519 99.70% 5,030,963 0.30% 76,273,736 Jeremy Levine 1,665,712,404 98.21% 30,364,079 1.79% 76,273,736 Prashanth Mahendra-Rajah 1,687,117,698 99.47% 8,958,784 0.53% 76,273,736 Joseph Natale 1,534,092,144 90.45% 161,984,336 9.55% 76,273,736 Kevin Scott 1,692,124,196 99.77% 3,952,285 0.23% 76,273,736 Toby Shannan 1,692,107,202 99.77% 3,969,280 0.23% 76,273,736 Fidji Simo 1,639,426,472 96.66% 56,649,985 3.34% 76,273,736 2.”

SHOPIFY INC. shareholders approved Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.

“The shareholders approved the appointment of PricewaterhouseCoopers LLP as auditors of the Company until the close of the Company's next annual meeting of shareholders at such remuneration to be fixed by the Board.”

SHOPIFY INC. shareholders approved Election of Directors at the 2026-06-16 meeting.

“Each of the 10 nominees listed below was elected as a director of the Company to hold office until the Company's next annual meeting of shareholders or until their successor is duly appointed.”

VirnetX Holding Corp shareholders approved Approval of the amendment to the Company’s Amended and Restated 2013 Equity Incentive Plan.

“Proposal 4: Approval of the amendment to the Company’s Amended and Restated 2013 Equity Incentive Plan: Votes For Votes Against Abstentions Broker Non-Votes 1,014,822 254,814 5,425 1,364,617”

VirnetX Holding Corp shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers.

“Proposal 3: Advisory vote to approve the compensation of the Company’s named executive officers: Votes For Votes Against Abstentions Broker Non-Votes 1,177,363 93,643 4,055 1,364,617”

VirnetX Holding Corp shareholders approved Ratification of the appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-12-31 meeting.

“Proposal 2: Ratification of the appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 2,486,962 140,839 11,877”

VirnetX Holding Corp shareholders approved Election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders.

“Proposal 1: Election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders: Votes For Votes Withheld Broker Non-Votes Kendall Larsen 1,229,553 45,508 1,364,617 Gary W. Feiner 1,137,272 137,789 1,364,617”

Q32 Bio Inc. shareholders approved Non-Binding, Advisory Vote on the Compensation of the Company’s Named Executive Officers.

“Proposal No. 3 - Non-Binding, Advisory Vote on the Compensation of the Company’s Named Executive Officers: The stockholders of the Company approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.”

Q32 Bio Inc. shareholders approved Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-12-31 meeting.

“Proposal No. 2 - Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026: The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Q32 Bio Inc. shareholders approved Election of Class II Directors: Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D..

“Proposal No. 1 - Election of Class II Directors: The stockholders of the Company elected Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D., as Class II directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2029 and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.”

Usio, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“Proposal 3 – Ratification of the Appointment of Independent Registered Public Accounting Firm Our stockholders voted upon and approved the ratification of the appointment of Withum Smith+Brown, P.C., to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes on this proposal were as follows: FOR AGAINST ABSTAIN 18,464,009 979,087 11,926”

Usio, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-10 meeting.

“Proposal 2 – Advisory Vote on Executive Compensation Our stockholders voted upon and approved, by non-binding advisory vote, the compensation of our named executive officers for the year ended December 31, 2025, as described in our proxy statement. The votes on this proposal were as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 10,166,645 2,672,494 45,035 6,570,848”

Usio, Inc. shareholders approved Election of two Class III Directors: Ernesto R. Beyer and Bradley Rollins at the 2026-06-10 meeting.

“Proposal 1A – Election of two Class III Directors: Ernesto R. Beyer and Bradley Rollins to serve until the 2029 Annual Meeting of Stockholders or until their successor is duly elected and qualified.”

ExlService Holdings, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the named executive officers at the 2026-06-16 meeting.

“Proposal 3 . Say-on-Pay was approved.”

ExlService Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026 at the 2026-06-16 meeting.

“Proposal 2 . Auditor Ratification was approved.”

ExlService Holdings, Inc. shareholders approved Election of seven members of the board of directors at the 2026-06-16 meeting.

“Proposal 1 . Each of the seven nominees for election to the Company’s board of directors was duly elected to serve as a director for a term of one year, until the 2027 annual meeting of stockholders, or until his or her successor is duly elected and qualified in accordance with the by-laws of the Company.”

SkyWater Technology, Inc shareholders approved Ratification of the Appointment of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal 2026 at the 2026-06-10 meeting.

“Ratification of the Appointment of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal 2026 The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for fiscal 2026 by the following votes: Votes For Votes Against Abstain 38,561,892 94,418 216,869”

SkyWater Technology, Inc shareholders approved Election of Nine Directors to Hold Office Until the Company’s 2027 Annual Meeting of Stockholders at the 2026-06-10 meeting.

“Election of Nine Directors to Hold Office Until the Company’s 2027 Annual Meeting of Stockholders The Company’s stockholders elected nine directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified by the following votes: Name Votes For Votes Withheld Broker Non-Votes Timothy E. Baxter 28,070,754 2,324,562 8,477,863 Edward M. Daly 29,993,959 401,357 8,477,863 Nancy Fares 29,962,582 432,734 8,477,863 Dennis J. Goetz 17,997,261 12,398,055 8,477,863 Joseph J. Humke 24,674,695 5,720,621 8,477,863 Andrew D. C. LaFrence 28,334,349 2,060,967 8,477,863 Tammy J. Miller 28,228,743 2,166,573 8,477,863 Thomas Sonderman 30,097,653 297,663 8,477,863 Loren A. Unterseher 30,082,040 313,276 8,477,863”

Better Home & Finance Holding Co shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified. Votes For Votes Against Abstentions Broker Non-Votes 20,575,834 37,151 18,591 —”

Better Home & Finance Holding Co shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1 - Election of Directors . Each of the following nominees was elected to serve as a director for a term expiring at the next annual meeting of stockholders of the Company and until their successors are elected and qualified or until their earlier death, resignation, disqualification or removal. Name of Nominee Votes For Votes Against Abstentions Broker Non-Votes Harit Talwar 10,256,829 5,637,357 695,422 4,041,968 Vishal Garg 16,511,173 76,135 2,300 4,041,968 David Barse 14,619,686 1,964,621 5,301 4,041,968 Michael Farello 14,820,419 1,073,629 695,560 4,041,968 Hugh R. Frater 16,550,106 34,191 5,311 4,041,968 Arnaud Massenet 12,918,058 2,975,901 695,649 4,041,968 Bhaskar Menon 13,497,382 2,396,679 695,547 4,041,968 Prabhu Narasimhan 14,383,460 1,511,104 695,044 4,041,968”

NEXSTAR MEDIA GROUP, INC. shareholders approved Approval of 2026 Long-Term Omnibus Incentive Plan at the 2026-06-16 meeting.

“Proposal 4 The voting results of the proposal to approve the 2026 Long-Term Omnibus Incentive Plan were as follows: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 26,214,589 763,457 24,225 1,660,378”

NEXSTAR MEDIA GROUP, INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent auditor at the 2026-06-16 meeting.

“Proposal 3 The voting results of the proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 were as follows: FOR AGAINST ABSTENTIONS 27,832,434 809,166 21,049”

NEXSTAR MEDIA GROUP, INC. shareholders approved Advisory vote to approve executive compensation at the 2026-06-16 meeting.

“Proposal 2 The voting results of the proposal to approve, by an advisory vote, the compensation of the Company’s named executive officers for the year ended December 31, 2025 as reported in the Company’s 2026 Proxy Statement, were as follows: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 25,392,200 1,563,609 46,462 1,660,378”

NEXSTAR MEDIA GROUP, INC. shareholders approved Election of nine nominees to serve as directors at the 2026-06-16 meeting.

“Proposal 1 The voting results of the proposal to elect nine nominees to each serve as director until the 2026 annual meeting of stockholders were as follows: FOR AGAINST ABSTENTIONS BROKER NON-VOTES Perry A. Sook 26,191,038 796,925 14,308 1,660,378 Geoff Armstrong 24,856,702 2,130,552 15,017 1,660,378 Bernadette S. Aulestia 26,887,852 97,771 16,648 1,660,378 Jay M. Grossman 22,231,210 4,756,033 15,028 1,660,378 Ellen Johnson 26,767,886 218,547 15,838 1,660,378 C. Thomas McMillen 25,591,338 1,391,724 19,209 1,660,378 Lisbeth McNabb 24,534,861 2,448,627 18,783 1,660,378 John R. Muse 22,260,293 4,721,383 20,595 1,660,378 Tony Wells 26,861,174 126,156 14,941 1,660,378”

HERON THERAPEUTICS, INC. /DE/ shareholders approved Ratification of adoption of Tax Benefits Preservation Plan (non-binding advisory) at the 2026-06-11 meeting.

“Proposal 6: The Company’s stockholders ratified, on a nonbinding advisory basis, the adoption of the Tax Benefits Preservation Plan: For Against Abstain Broker Non-Votes 88,182,895 3,442,815 186,146 50,116,083”

HERON THERAPEUTICS, INC. /DE/ shareholders approved Approval of amendment to the 1997 Employee Stock Purchase Plan, increasing authorized shares by 10,000,000 at the 2026-06-11 meeting.

“Proposal 5: The Company’s stockholders approved the amendment to the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by an additional 10,000,000 shares: For Against Abstain Broker Non-Votes 83,765,950 6,496,205 1,549,701 50,116,083”

HERON THERAPEUTICS, INC. /DE/ shareholders approved Approval of amendment and restatement of the 2007 Amended and Restated Equity Incentive Plan, increasing authorized shares by 16,560,000 at the 2026-06-11 meeting.

“Proposal 4: The Company’s stockholders approved the amendment and restatement of the Company’s 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares: For Against Abstain Broker Non-Votes 75,620,741 13,846,030 2,345,085 50,116,083”

HERON THERAPEUTICS, INC. /DE/ shareholders approved Non-binding advisory vote on compensation of Named Executive Officers for fiscal year 2025 at the 2026-06-11 meeting.

“Proposal 3: The Company’s stockholders approved, on a nonbinding advisory basis, the compensation paid to the Company’s Named Executive Officers during the fiscal year ended December 31, 2025: For Against Abstain Broker Non-Votes 77,315,474 12,117,861 2,378,521 50,116,083”

HERON THERAPEUTICS, INC. /DE/ shareholders approved Ratification of appointment of Withum Smith+Brown, PC as independent registered public accounting firm for fiscal year 2026 at the 2026-06-11 meeting.

“Proposal 2: The Company’s stockholders ratified the appointment of Withum Smith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Votes 139,715,514 1,706,193 506,232 0”

HERON THERAPEUTICS, INC. /DE/ shareholders approved Election of seven director nominees at the 2026-06-11 meeting.

“Proposal 1: The Company’s stockholders elected the seven director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Name of Director Nominee For Against Abstain Broker Non-Votes Mr. Collard 87,289,779 4,336,869 185,208 50,116,083 Mr. Cusack Dr. Dissanaike 88,537,725 87,960,023 3,088,305 3,729,614 185,826 122,219 50,116,083 50,116,083 Mr. Johnson 87,703,801 3,972,919 135,136 50,116,083 Mr. Kaseta 88,236,408 3,424,597 150,851 50,116,083 Mr. Morgan 88,295,437 3,381,282 135,137 50,116,083 Mr. Waage 85,276,872 6,399,195 135,789 50,116,083”

STANDARD PREMIUM FINANCE HOLDINGS, INC. shareholders approved Authorization to amend the Articles of Incorporation to remove a provision which requires that the Company have eleven members on the Board of Directors at the 2026-06-12 meeting.

“Proposal 4 – Authorization to amend the Articles of Incorporation to remove a provision which requires that the Company have eleven members on the Board of Directors Shareholders approved the amendment of the Articles of Incorporation to remove a provision which requires that the Company have 11 members on the Board of Directors. The voting results for this proposal are as follows: Votes For Votes Against Abstain 1,723,167 — 286,748 There were no broker non-votes.”

STANDARD PREMIUM FINANCE HOLDINGS, INC. shareholders approved Desired frequency of the non-binding advisory vote to approve executive compensation at the 2026-06-12 meeting.

“Proposal 3 – Desired frequency of the non-binding advisory vote to approve executive compensation Shareholders approved a frequency of three years regarding the frequency of future advisory votes on named executive officer compensation. The voting results for this proposal are as follows: Three Years Two Years One Year 1,250,939 418,713 340,263 There were no abstentions or broker non-votes.”

STANDARD PREMIUM FINANCE HOLDINGS, INC. shareholders approved Advisory resolution to approve executive compensation at the 2026-06-12 meeting.

“Proposal 2 – Advisory resolution to approve executive compensation Shareholders approved, on an advisory basis, the Company’s compensation of its named executive officers, as disclosed in the 2026 Annual Meeting Proxy Statement. The voting results for this proposal are as follows: Votes For Votes Against Abstain 1,949,450 — 60,465 There were no broker non-votes.”

STANDARD PREMIUM FINANCE HOLDINGS, INC. shareholders approved Election of Directors at the 2026-06-12 meeting.

“Proposal 1 – Election of Directors Shareholders approved the election of three directors to serve as directors for a three-year term to expire at the 2029 Annual Meeting. The voting results for this proposal are as follows: Nominee Votes For Votes Withheld William Koppelmann 2,009,915 — Mark Kutner, MD 2,009,915 — Scott Howell, MD 2,009,915 — There were no abstentions or broker non-votes.”

Global Indemnity Group, LLC shareholders approved Advisory vote on executive compensation (say-on-pay) at the 2026-06-10 meeting.

“Proposal 3: To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as set forth in the Proxy Statement. The proposal was approved by the following vote: Votes For Votes Against Abstain Broker non-votes 41,963,705 469,379 96,831 897,550”

Global Indemnity Group, LLC shareholders approved Ratification of appointment of independent auditors for fiscal year ended December 31, 2026 at the 2026-06-10 meeting.

“Proposal 2: To ratify the appointment of the Company's independent auditors for the fiscal year ended December 31, 2026. The proposal was approved by the following vote: Votes For Votes Against Abstain Broker non-votes 42,862,850 541,476 23,139 0”

Global Indemnity Group, LLC shareholders approved Election of Director at the 2026-06-10 meeting.

“Proposal 1: Election of Director The following individual was elected to the Company's Board of Directors to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until a successor is duly elected and qualified: Name Votes For Votes Against Abstain Broker non-votes Seth J. Gersch 41,885,325 640,260 4,330 897,550”

Latch, Inc. shareholders approved Advisory vote to approve compensation of the named executive officers for the year ended December 31, 2025 at the 2026-06-10 meeting.

“Proposal 3 - Advisory vote to approve compensation of the named executive officers for the year ended December 31, 2025. The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. For Against Abstained Broker Non-Votes 57,646,930 540,959 26,524 32,561,226”

Latch, Inc. shareholders approved Ratification of the appointment of BDO USA, P.C. as the Company’s independent public accounting firm for the year ending December 31, 2026 at the 2026-06-10 meeting.

“Proposal 2 - Ratification of the appointment of BDO USA, P.C. as the Company’s independent public accounting firm for the year ending December 31, 2026. The stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026. For Against Abstained Broker Non-Votes 90,335,155 306,413 134,071 0”

Latch, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1 - Election of Directors. Each of the nominees for director was elected to serve until the expiration of his or her respective term and until his or her successor is duly elected and qualified. Nominee For Withheld Broker Non-Votes Peter Campbell 56,070,367 2,144,046 32,561,226 Patricia Han 56,153,129 2,061,284 32,561,226 Raju Rishi 56,026,406 2,188,008 32,561,226 J. Allen Smith 55,469,102 2,745,311 32,561,226 Robert J. Speyer 52,956,188 5,258,225 32,561,226 Andrew Sugrue 55,557,604 2,656,809 32,561,226”

PALVELLA THERAPEUTICS, INC. shareholders approved Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5.

“Proposal 6 – Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5. The stockholders approved an adjournment of the Annual Meeting to the extent there were insufficient votes to approve Proposal 5, but such an adjournment was not necessary in light of the approval of Proposal 5 at the Annual Meeting. The voting results for the adjournment proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 7,649,243 2,519,068 7,743 1,401,415”

PALVELLA THERAPEUTICS, INC. shareholders approved Approval of an amendment to the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan to increase the authorized shares issuable thereunder by 750,000 shares.

“Proposal 5 – Approval of an amendment to the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan to increase the authorized shares issuable thereunder by 750,000 shares. The stockholders approved the Plan Amendment, as follows: Votes For Votes Against Abstentions Broker Non-Votes 7,692,709 2,475,470 7,875 1,401,415”

PALVELLA THERAPEUTICS, INC. shareholders approved Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company’s named executive officers.

“Proposal 4 - Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company’s named executive officers. The stockholders approved, on an advisory basis, the preferred frequency of future advisory votes on compensation of the Company’s named executive officers, as follows: Every Year Every 2 Years Every 3 Years Abstain Broker Non-Votes 9,183,170 1,002 984,332 7,550 1,401,415”

PALVELLA THERAPEUTICS, INC. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers in 2025.

“Proposal 3 - Approval, on an advisory basis, of the compensation of the Company’s named executive officers in 2025. The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers in 2025, as follows: Votes For Votes Against Abstentions Broker Non-Votes 10,008,180 160,717 7,157 1,401,415”

PALVELLA THERAPEUTICS, INC. shareholders approved Ratification of Independent Registered Public Accountant.

“Proposal 2 - Ratification of Independent Registered Public Accountant. The appointment of Ernst &Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was ratified, as follows: Votes For Votes Against Abstentions 11,557,687 13,216 6,566”

PALVELLA THERAPEUTICS, INC. shareholders approved Election of Class III Directors.

“Proposal 1 - Election of Class III Directors. George M. Jenkins, Todd C. Davis and John Doux, M.D . were elected to the Board as Class III directors to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors, if any, are duly elected and qualified or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows: Name Votes For Votes Withheld Broker Non-Votes George M. Jenkins 9,907,220 268,834 1,401,415 Todd C. Davis 8,321,303 1,854,751 1,401,415 John Doux, M.D. 9,958,528 217,526 1,401,415”

Vital Farms, Inc. shareholders approved Advisory vote on the compensation of named executive officers as disclosed in the Proxy Statement at the 2026-06-10 meeting.

“Proposal No. 3 : Stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The votes were cast as follows: Votes For Votes Against Abstained Broker Non-Votes 25,303,758 2,246,660 298,218 7,551,586”

Vital Farms, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 27, 2026 at the 2026-06-10 meeting.

“Proposal No. 2 : Stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 27, 2026. The votes were cast as follows: Votes For Votes Against Abstained 35,004,645 374,653 20,924”

Vital Farms, Inc. shareholders approved Election of two directors to serve until 2029 annual meeting at the 2026-06-10 meeting.

“Proposal No. 1 : Stockholders elected each of the two nominees to serve as directors until the 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Broker Non-Votes Russell Diez-Canseco 22,296,432 5,552,204 7,551,586 Kelly Kennedy 22,047,980 5,800,656 7,551,586”

Azitra, Inc. shareholders approved Adoption of amendment to Certificate of Incorporation to increase authorized common stock from 200,000,000 shares to 750,000,000 shares. at the 2026-06-15 meeting.

“Proposal No. 2. Stockholders approved the adoption of an amendment to the Company’s Certificate of Incorporation to increase the authorized number of shares of the Company’s common stock from 200,000,000 shares to 750,000,000 shares, with shares voted as follows: Votes Non-Votes 713,487 476,452 26,523 4,861,794”